Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Gadolinium-hida
2. Gd-hida
3. Hepato-iminodiacetic Acid
4. Hida
5. N-(carboxymethyl)-n-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)glycine
1. 59160-29-1
2. Hida
3. N-(2,6-dimethylphenylcarbamoylmethyl)iminodiacetic Acid
4. Hepato-scan
5. Hid-a
6. (((2,6-xylylcarbamoyl)methyl)imino)diacetic Acid
7. Acetic Acid, (((2,6-xylylcarbamoyl)methyl)imino)di-
8. 2-[carboxymethyl-[2-(2,6-dimethylanilino)-2-oxoethyl]amino]acetic Acid
9. N-(2,6-dimethyl-phenyl-carbamoyl-methyl)-iminodiacetic Acid
10. Iminodiacetic Acid, N-(2,6-dimethyl-phenyl-carbamoylmethyl)-
11. N-(n'-(2,6-dimethylphenyl)carbamoylmethyl)iminodiacetic Acid
12. Ek22qv7701
13. 2,2'-((2-((2,6-dimethylphenyl)amino)-2-oxoethyl)azanediyl)diacetic Acid
14. Ncgc00164491-01
15. Ncgc00164491-02
16. N-(carboxymethyl)-n-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)glycine
17. Acetic Acid, 2,2'-(n-(2,6-dimethylphenylcarbamoylmethyl)imino)di-
18. Glycine, N-(carboxymethyl)-n-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)-
19. Glycine, N-(carboxymethyl)-n-[2-[(2,6-dimethylphenyl)amino]-2-oxoethyl]-
20. Dsstox_cid_26389
21. Dsstox_rid_81569
22. Dsstox_gsid_46389
23. Lidofenine
24. Lidofenino
25. Lidofeninum
26. Lidofenin [usan:inn]
27. Lidofenine [inn-french]
28. Lidofeninum [inn-latin]
29. Lidofenino [inn-spanish]
30. N-(carboxymethyl)-n-[2-[(2,6-dimethylphenyl)amino]-2-oxoethyl]glycine
31. Cas-59160-29-1
32. [[(2,6-xylylcarbamoyl)methyl]imino]diacetic Acid
33. Einecs 261-636-4
34. Brn 2820306
35. Unii-ek22qv7701
36. Hepato-scan (tn)
37. Lidofenin [inn]
38. Lidofenin [ii]
39. Lidofenin [mi]
40. Lidofenin (usan/inn)
41. Lidofenin [usan]
42. Lidofenin [who-dd]
43. Mls004773974
44. Schembl214472
45. Zinc1618
46. Chembl1400608
47. Dtxsid2046389
48. Chebi:135229
49. Tox21_112129
50. Mfcd00038399
51. Akos009158948
52. Tox21_112129_1
53. Smr001550302
54. Db-053332
55. D1730
56. Ft-0630711
57. D04730
58. T71106
59. N-(2,6-xylidinocarbonylmethyl)iminodiacetic Acid
60. A869256
61. Sr-01000939575
62. Sr-01000939575-2
63. N-(2,6-dimethylacetanilide) Iminodiacetic Acid
64. Q27277215
65. 2,2'-(2-(2,6-dimethylphenylamino)-2-oxoethylazanediyl)diacetic Acid
66. 2,2-((2-((2,6-dimethylphenyl)amino)-2-oxoethyl)azanediyl)diacetic Acid
67. Lidofenin, Lidofenin (n-(2,6-dimethylphenyl-carbamoylmethyl)iminodiacetic Acid)
| Molecular Weight | 294.30 g/mol |
|---|---|
| Molecular Formula | C14H18N2O5 |
| XLogP3 | -1.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | 294.12157168 g/mol |
| Monoisotopic Mass | 294.12157168 g/mol |
| Topological Polar Surface Area | 107 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 373 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Lidofenin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lidofenin, including repackagers and relabelers. The FDA regulates Lidofenin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lidofenin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lidofenin supplier is an individual or a company that provides Lidofenin active pharmaceutical ingredient (API) or Lidofenin finished formulations upon request. The Lidofenin suppliers may include Lidofenin API manufacturers, exporters, distributors and traders.
Lidofenin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lidofenin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lidofenin GMP manufacturer or Lidofenin GMP API supplier for your needs.
A Lidofenin CoA (Certificate of Analysis) is a formal document that attests to Lidofenin's compliance with Lidofenin specifications and serves as a tool for batch-level quality control.
Lidofenin CoA mostly includes findings from lab analyses of a specific batch. For each Lidofenin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lidofenin may be tested according to a variety of international standards, such as European Pharmacopoeia (Lidofenin EP), Lidofenin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lidofenin USP).
LOOKING FOR A SUPPLIER?
